US 2026/0109955 A1Published application

Method for separating and purifying cvb1

AssigneeHangzhou Yangshengtang Biopharma Co., Ltd.

InventorsLisheng Yang, Bing Liu, Tianyu Ding, Chengfa Ji, Limin Wang, Wei Shi

Life of this patent

Estimating the term…

Abstract

The present invention relates to a method for separating and purifying CVB1, and particularly, relates to a method for purifying CVB1 virus by using a heparin affinity medium.

Claims18

Dependent claims

A method for purifying CVB1 (Coxsackievirus type B1) in a sample, which comprises a step of contacting the sample with a heparin affinity medium.

Dependencies are inferred from the claim text.

Facts

Application: 18/860,522Filed 30 Nov 2023
Priority: CN 202211541435.81 Dec 2022
Published: 23 Apr 2026
Term ends: Not estimatedThe source records don’t support an estimate.

Classification10 codes

C12N 7/00
Viruses
B01D 15/3804
Involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or…
B01D 15/3823
Affinity chromatography: of other types, e.g. avidin, streptavidin or biotin
B01D 15/3847
Involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or…

Family

No related US applications are recorded in the indexed filing history.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results